Research output per year
Research output per year
Search results
-
2024
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy
Crombie, J. L., Graff, T., Falchi, L., Karimi, Y. H., Bannerji, R., Nastoupil, L., Thieblemont, C., Ursu, R., Bartlett, N., Nachar, V., Weiss, J., Osterson, J., Patel, K., Brody, J., Abramson, J. S., Lunning, M., Shah, N. N., Ayed, A., Kamdar, M. & Parsons, B. & 13 others, , Apr 18 2024, In: Blood. 143, 16, p. 1565-1575 11 p.Research output: Contribution to journal › Comment/debate
Open Access25 Scopus citations -
2021
Author Correction: Hodgkin lymphoma (Nature Reviews Disease Primers, (2020), 6, 1, (61), 10.1038/s41572-020-0189-6)
Connors, J. M., Cozen, W., Steidl, C., Carbone, A., Hoppe, R. T., Flechtner, H. H. & Bartlett, N. L., Dec 2021, In: Nature Reviews Disease Primers. 7, 1, 79.Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations -
CD3xCD20 bispecific T-cell redirectors for relapsed or refractory B-cell lymphoma
Ghobadi, A. & Bartlett, N. L., Sep 25 2021, In: The Lancet. 398, 10306, p. 1109-1110 2 p.Research output: Contribution to journal › Comment/debate
2 Scopus citations -
2020
The justification of vincristine dose capping: tradition, tradition…tradition!
Bartlett, N. L., Apr 15 2020, In: Leukemia and Lymphoma. 61, 5, p. 1007-1009 3 p.Research output: Contribution to journal › Comment/debate
1 Scopus citations -
2019
Erratum: A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma (Blood (2019) 133: 11 (1201-1204) DOI: 10.1182/blood-2018-11-886457)
Martin, P., Bartlett, N. L. & Blum, K. A., Sep 12 2019, In: Blood. 134, 11, p. 908 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
2016
Radiation for early-stage nodular lymphocyte-predominant Hodgkin lymphoma: A double-edged sword?
Rashidi, A. & Bartlett, N. L., Feb 1 2016, In: Leukemia and Lymphoma. 57, 2, p. 249-251 3 p.Research output: Contribution to journal › Comment/debate
-
2014
Erratum: Progressive multifocal leukoencephalopathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin (Leukemia and Lymphoma (2012) 53:11 (2283-2286))
Wagner-Johnston, N. D., Bartlett, N. L., Cashen, A. & Berger, J. R., Jan 2014, In: Leukemia and Lymphoma. 55, 1, p. 229 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
2012
Erratum: A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma (Cancer DOI: 10.1002/cncr.26510)
Cheson, B. D., Bartlett, N. L., Vose, J. M., Lopez-Hernandez, A., Seiz, A. L., Keating, A. T., Shamsili, S., Papadopoulos, K. P. & Papadopoulos, K. P., Sep 1 2012, In: Cancer. 118, 17, p. 4365 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
2009
Something old, something new: Options for treating relapsed mantle cell lymphoma
Wagner-Johnston, N. D. & Bartlett, N. L., Jul 14 2009, In: Oncology. 23, 8Research output: Contribution to journal › Comment/debate